Monogram Orthopaedics (MGRM) Competitors $5.39 +0.03 (+0.56%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$5.35 -0.04 (-0.74%) As of 08/1/2025 06:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MGRM vs. SIBN, IRMD, EMBC, BBNX, AXGN, AVNS, KIDS, CBLL, BVS, and SMLRShould you be buying Monogram Orthopaedics stock or one of its competitors? The main competitors of Monogram Orthopaedics include SiBone (SIBN), iRadimed (IRMD), Embecta (EMBC), Beta Bionics (BBNX), AxoGen (AXGN), Avanos Medical (AVNS), OrthoPediatrics (KIDS), CeriBell (CBLL), Bioventus (BVS), and Semler Scientific (SMLR). These companies are all part of the "medical equipment" industry. Monogram Orthopaedics vs. Its Competitors SiBone iRadimed Embecta Beta Bionics AxoGen Avanos Medical OrthoPediatrics CeriBell Bioventus Semler Scientific SiBone (NASDAQ:SIBN) and Monogram Orthopaedics (NASDAQ:MGRM) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations. Does the media prefer SIBN or MGRM? In the previous week, Monogram Orthopaedics had 1 more articles in the media than SiBone. MarketBeat recorded 3 mentions for Monogram Orthopaedics and 2 mentions for SiBone. SiBone's average media sentiment score of 0.51 beat Monogram Orthopaedics' score of 0.00 indicating that SiBone is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SiBone 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Monogram Orthopaedics 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals and insiders have more ownership in SIBN or MGRM? 98.1% of SiBone shares are owned by institutional investors. Comparatively, 0.5% of Monogram Orthopaedics shares are owned by institutional investors. 4.0% of SiBone shares are owned by company insiders. Comparatively, 28.1% of Monogram Orthopaedics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has preferable valuation & earnings, SIBN or MGRM? Monogram Orthopaedics has lower revenue, but higher earnings than SiBone. SiBone is trading at a lower price-to-earnings ratio than Monogram Orthopaedics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSiBone$167.18M4.43-$30.91M-$0.64-27.17Monogram Orthopaedics$370K519.92-$16.33M-$0.45-11.98 Which has more volatility and risk, SIBN or MGRM? SiBone has a beta of 0.91, suggesting that its stock price is 9% less volatile than the S&P 500. Comparatively, Monogram Orthopaedics has a beta of 0.67, suggesting that its stock price is 33% less volatile than the S&P 500. Do analysts recommend SIBN or MGRM? SiBone presently has a consensus target price of $22.50, indicating a potential upside of 29.38%. Monogram Orthopaedics has a consensus target price of $5.40, indicating a potential upside of 0.19%. Given SiBone's higher possible upside, analysts clearly believe SiBone is more favorable than Monogram Orthopaedics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SiBone 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Monogram Orthopaedics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Is SIBN or MGRM more profitable? Monogram Orthopaedics has a net margin of 0.00% compared to SiBone's net margin of -15.03%. SiBone's return on equity of -16.00% beat Monogram Orthopaedics' return on equity.Company Net Margins Return on Equity Return on Assets SiBone-15.03% -16.00% -11.69% Monogram Orthopaedics N/A -115.71%-92.75% SummaryMonogram Orthopaedics beats SiBone on 9 of the 17 factors compared between the two stocks. Get Monogram Orthopaedics News Delivered to You Automatically Sign up to receive the latest news and ratings for MGRM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MGRM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MGRM vs. The Competition Export to ExcelMetricMonogram OrthopaedicsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$191.29M$6.77B$5.47B$9.53BDividend YieldN/A1.32%4.74%4.08%P/E Ratio-11.9820.9428.6723.80Price / Sales519.9259.01422.2688.08Price / CashN/A20.5035.4557.96Price / Book12.834.468.275.55Net Income-$16.33M$174.54M$3.24B$259.03M7 Day Performance-5.11%-5.27%-3.63%-4.56%1 Month Performance85.22%-3.94%4.40%4.49%1 Year Performance128.39%8.26%25.97%18.05% Monogram Orthopaedics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MGRMMonogram Orthopaedics1.2986 of 5 stars$5.39+0.6%$5.40+0.2%+128.4%$191.29M$370K-11.9828News CoveragePositive NewsSIBNSiBone3.9258 of 5 stars$17.60+2.0%$22.50+27.8%+17.2%$735.10M$167.18M-27.50350Upcoming EarningsIRMDiRadimed4.1857 of 5 stars$57.11+1.4%$72.00+26.1%+43.4%$716.11M$73.24M36.85110News CoverageEarnings ReportDividend AnnouncementGap UpEMBCEmbecta4.6464 of 5 stars$11.33-3.4%$19.00+67.7%-35.3%$685.53M$1.12B12.592,100News CoverageUpcoming EarningsBBNXBeta Bionics2.3438 of 5 stars$13.99-5.7%$23.44+67.6%N/A$643.40M$69.83M0.00294Trending NewsEarnings ReportAnalyst ForecastLockup ExpirationAnalyst RevisionAXGNAxoGen2.3587 of 5 stars$12.99-2.8%$24.50+88.6%+55.3%$608.92M$187.34M-86.59450Upcoming EarningsHigh Trading VolumeAVNSAvanos Medical2.3241 of 5 stars$12.02+0.1%N/A-53.7%$555.39M$687.80M-1.442,227News CoverageUpcoming EarningsKIDSOrthoPediatrics3.7468 of 5 stars$22.39-1.6%$35.83+60.0%-33.2%$552.52M$204.73M-12.79200News CoverageUpcoming EarningsCBLLCeriBell2.2299 of 5 stars$14.96-1.1%$32.14+114.9%N/A$546.84M$65.44M0.00N/ABVSBioventus0.9945 of 5 stars$6.53-0.6%N/AN/A$539.69M$573.28M-13.601,200SMLRSemler Scientific2.5482 of 5 stars$39.25+3.1%$82.00+108.9%+14.4%$525.05M$49.23M-15.04120Upcoming EarningsGap Down Related Companies and Tools Related Companies SiBone Competitors iRadimed Competitors Embecta Competitors Beta Bionics Competitors AxoGen Competitors Avanos Medical Competitors OrthoPediatrics Competitors CeriBell Competitors Bioventus Competitors Semler Scientific Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MGRM) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Monogram Orthopaedics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Monogram Orthopaedics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MGRM Stock Alerts